Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
Chemistry & Biodiversity|May 16, 2024
Suberitolactams A-D and Suberitopyridines A-B: New γ-lactam and Pyridine Alkaloids Isolated from the South China Sea Sponge Pseudospongosorites suberitoidesZhe Wang, Guo-Qiang Li, Han-Ting ZhangNeuroscience Bulletin|October 20, 2020
Neuroprotective Effects of Molecular Hydrogen: A Critical ReviewWei Chen, Han-Ting Zhang, Shu-Cun QinPsychopharmacology|August 5, 2003
Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in ratsHan-Ting Zhang, Ying Huang, James M O'DonnellPsychopharmacology|February 25, 2014
Mice deficient in phosphodiesterase-4A display anxiogenic-like behaviorRolf T Hansen, Marco Conti, Han-Ting ZhangAdvances in Neurobiology|September 29, 2017
Targeting Phosphodiesterases in Pharmacotherapy for Substance DependenceRui-Ting Wen, Jian-Hui Liang, Han-Ting ZhangPsychopharmacology|April 18, 2018
Cyclic nucleotide phosphodiesterases: potential therapeutic targets for alcohol use disorderRui-Ting Wen, Fang-Fang Zhang, Han-Ting ZhangExpert Opinion on Therapeutic Targets|July 26, 2013
PDE4 as a target for cognition enhancementWito Richter, Frank S Menniti, Han-Ting Zhang, et al.Journal of Alzheimer'S Disease : JAD|May 18, 2020
The Role of Synaptic Dysfunction in Alzheimer's DiseaseYixuan Amy Pei, Julie Davies, Melanie Zhang, et al.Journal of Medicinal Chemistry|March 5, 2009
Dual inhibitors of phosphodiesterase-4 and serotonin reuptakeJohn R Cashman, Troy Voelker, Han-Ting Zhang, et al.Current Pharmaceutical Design|August 28, 2014
Phosphodiesterase: an interface connecting cognitive deficits to neuropsychiatric and neurodegenerative diseasesZhen-Zhen Wang, Yi Zhang, Han-Ting Zhang, et al.Pageof 12